SCHEMBL14099343

SCHEMBL14099343

CC(C)C(=O)Nc1ccccc1Nc1ccc(Br)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.57
KMT2A Q03164 7/20 0.57
MAPT P10636 4/20 0.57
ALDH1A1 P00352 3/20 0.57
RXFP1 Q9HBX9 2/20 0.57
MDM4 O15151 2/20 0.54
TP53 P04637 2/20 0.54
CETP P11597 1/20 0.51
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
HTT P42858 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
MDM2 Q00987 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6264293 0.87 MAPT (0.69) MEN1KMT2AMAPTALDH1A1RXFP1
SCHEMBL14499606 0.84 ALDH1A1 (0.56) MEN1KMT2AMAPTALDH1A1RXFP1
SCHEMBL338788 0.82 SIRT2 (0.54) MEN1KMT2AMAPTALDH1A1RXFP1
SCHEMBL20761408 0.81 MDM4 (0.77) MEN1KMT2AMAPTALDH1A1RXFP1
SCHEMBL12805040 0.79 MEN1 (0.61) MEN1KMT2AMAPTALDH1A1RXFP1
SCHEMBL14499598 0.78 GAA (0.57) MEN1KMT2AMAPTALDH1A1RAB9A
SCHEMBL12946208 0.78 MEN1 (0.69) MEN1KMT2AMAPTRXFP1TP53
SCHEMBL13390992 0.76 TP53 (0.65) MEN1KMT2AMAPTALDH1A1RXFP1
SCHEMBL338138 0.76 MEN1 (0.67) MEN1KMT2AMAPTMDM4TP53
SCHEMBL15888707 0.76 TP53 (0.58) MEN1KMT2AMAPTTP53RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956007-A1 NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME Idemitsu Kosan Co., Ltd. (JP) 2008-08-13 EP disclosed
US-20070138950-A1 NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-21 US disclosed
US-20070138950-A1 NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070138950-A1 NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME EHD1, HCN2, ODC1 MEN1 936/4885KMT2A 1030/4885MAPT 3456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.